Sarah Liu

Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom.

Part of Salix Pharmaceuticals Ltd., Salix Pharmaceuticals, Inc. is a company that manufactures pharmaceutical products. The company is based in Sunnyvale, CA.

Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL.

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

Bank of America, NA engages in the provision of commercial banking services. It offers financing, checking and savings accounts, and investment banking for individual clients. The company was founded on March 1, 1927 and is headquartered in Charlotte, NC.

The National Governors Association operates as a bipartisan organization for governors on a national level. The non-profit company is based in Washington.

Aruna Bio, Inc. manufactures and provides neural stem cells. Its products include neuronet pure human neurons screening kit, neuronet pure human neurons discovery kit, co-culture kit hastropro-neuronet, hastropro human astrocytes kit and motor neurons GFP+htscreening kit. The company was founded by James Stice and Steven L. Stice in 2003 and is headquartered in Athens, GA.

RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel.

DJE Advisors LLC is an independent hedge fund manager headquartered in Englewood, New Jersey. Founded in 2008, the firm provides investment advisory and management services to high-net-worth clients.

LifeSci Advisors LLC is an investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach. Their services are designed to increase clients? visibility within the investment community and to educate investors about the opportunity.

LifeSci Capital LLC is a full-service investment bank that offers financial and strategic advisory services, institutional outreach, and research to leading life sciences companies. The private company is based in New York, NY. The company's team of investment bankers has extensive experience at bulge bracket and specialty investment banks. LifeSci Capital's highly regarded team of analysts generates differentiated, proprietary research and covers companies across all major therapeutic areas. The company was founded in 2013 by Andrew Ian McDonald and Michael Yehuda Rice. Andrew Ian McDonald has been the CEO since 2013.

LifeSci Index Partners LLC (LSIP) is an independent investment advisor headquartered in New York City. The firm was co-founded by Paul Yook, Andrew McDonald and Michael Rice in 2014. LSIP is an index provider of healthcare-based stock market indices and also serves as the investment sub-advisor for the BioShares exchange traded funds.

LifeSci Venture Partners (LifeSci Venture Partners) is a venture capital subsidiary of LifeSci Index Partners LLC founded in 2017 by Paul Inho Yook. The firm is headquartered in New York.

Part of Fordham Holdings Group, Inc., ThinkEquity LLC is a financial services company based in New York, NY. The company's model is centered around meeting the needs of its clients by assisting them in managing risk, enhancing their performance, and decreasing overall transaction costs.

Minovia Therapeutics Ltd. is a clinical stage company based in Tirat Carmel, Israel. Minovia Therapeutics is developing a therapeutic platform called mitochondrial augmentation technology (mat) that targets the root cause of diseases generated by mitochondrial dysfunction. The platform enriches patients' hematopoietic stem and progenitor cells with healthy mitochondria isolated from an allogeneic or syngeneic source. The Israeli company's initial clinical focus is on rare mitochondrial diseases for which there are no approved treatments, and the lead product, mnv-201, is composed of autologous hematopoietic stem cells enriched with healthy allogeneic mitochondria. Minovia Therapeutics completed an ind enabled phase i/ii clinical trial in Pearson syndrome, a fatal pediatric disease, and is planning to accelerate the clinical development for Pearson syndrome and expand the pipeline to other hematological/mitochondrial-related diseases. The company was founded in 2012 by Natalie Yivgi-Ohana, Uriel Halavee, Ephraim Aharonson, and Natalie Yivgi-Ohana has been the CEO since 2012.

Naia Rare Diseases, Inc. develops pharmaceutical drugs for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases. The firm offers NB 1001 for adult SBS, NB 1001 for pediatric SBS, and NB 1002, a GLP-2 agonist. The company was founded by H. Daniel Perez and Mark Bagnall in 2014 and is headquartered in Cayman Islands.

Aspargo Laboratories, Inc. is a clinical stage pharmaceutical company, which focuses on developing an oral spray formulation of sildenafil. Its products include Sildenafil Oral Spray, an oral liquid suspension of sildenafil citrate administered via a spray pump that dispenses 12.5 mg of sildenafil per push of the pump or via an individual single liquid unit dispensing 100 mg per unit. The company was founded in 2019 and is headquartered in Englewood Cliffs, NJ.

LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY.